Chemours Historical Financial Ratios
| CC Stock | USD 18.89 0.18 0.94% |
Chemours is presently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0409 or PTB Ratio of 8.43 will help investors to properly organize and evaluate Chemours financial condition quickly.
Chemours |
About Chemours Financial Ratios Analysis
ChemoursFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Chemours investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Chemours financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Chemours history.
Chemours Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Chemours stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Chemours sales, a figure that is much harder to manipulate than other Chemours Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Chemours Co dividend as a percentage of Chemours stock price. Chemours dividend yield is a measure of Chemours stock productivity, which can be interpreted as interest rate earned on an Chemours investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Chemours Co. There are two different methods for calculating Chemours invested capital: operating approach and financing approach. Understanding Chemours invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most ratios from Chemours' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' PTB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 48.22, whereas Price To Sales Ratio is forecasted to decline to 0.55.
| 2020 | 2022 | 2023 (projected) | Dividend Yield | 0.0402 | 0.0324 | 0.0317 | Price To Sales Ratio | 0.82 | 0.7 | 0.78 |
Chemours fundamentals Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 0.75 | 0.54 | 0.82 | 0.87 | 0.7 | 0.78 | |
| Dividend Yield | 0.0296 | 0.055 | 0.0402 | 0.0324 | 0.0317 | 0.0409 | |
| Ptb Ratio | 4.33 | 5.02 | 5.12 | 4.3 | 6.37 | 8.43 | |
| Days Sales Outstanding | 44.52 | 37.54 | 41.42 | 33.63 | 36.94 | 48.22 | |
| Book Value Per Share | 4.22 | 4.95 | 6.56 | 7.13 | 4.96 | 8.77 | |
| Operating Cash Flow Per Share | 3.94 | 4.9 | 4.97 | 4.85 | 3.73 | 5.05 | |
| Stock Based Compensation To Revenue | 0.003438 | 0.00322 | 0.005359 | 0.003974 | 0.002987 | 0.002599 | |
| Capex To Depreciation | 1.55 | 0.83 | 0.87 | 1.05 | 1.21 | 1.6 | |
| Pb Ratio | 4.33 | 5.02 | 5.12 | 4.3 | 6.37 | 8.43 | |
| Free Cash Flow Per Share | 1.03 | 3.28 | 3.29 | 2.88 | 1.25 | 2.46 | |
| Roic | 0.0148 | 0.13 | 0.17 | 0.15 | (0.0145) | (0.0138) | |
| Inventory Turnover | 4.14 | 4.16 | 4.52 | 3.69 | 3.49 | 4.98 | |
| Net Income Per Share | (0.32) | 1.33 | 3.69 | 3.72 | (1.6) | (1.52) | |
| Days Of Inventory On Hand | 88.24 | 87.84 | 80.81 | 98.97 | 104.53 | 65.67 | |
| Payables Turnover | 4.84 | 4.76 | 4.27 | 4.2 | 4.16 | 5.16 | |
| Research And Ddevelopement To Revenue | 0.0124 | 0.0145 | 0.0187 | 0.0174 | 0.0179 | 0.019 | |
| Capex To Revenue | 0.087 | 0.0537 | 0.0437 | 0.0452 | 0.0614 | 0.0716 | |
| Cash Per Share | 5.72 | 6.71 | 8.8 | 7.09 | 8.08 | 5.21 | |
| Pocfratio | 4.38 | 4.59 | 5.06 | 6.31 | 8.45 | 4.9 | |
| Interest Coverage | 0.82 | 2.42 | 4.8 | 5.6 | (0.44) | (0.42) | |
| Payout Ratio | 0.15 | (3.15) | 0.75 | 0.27 | (0.63) | (0.59) | |
| Capex To Operating Cash Flow | 0.74 | 0.33 | 0.34 | 0.41 | 0.67 | 0.78 | |
| Pfcf Ratio | 17.64 | 7.56 | 10.19 | 10.64 | 25.25 | 26.51 | |
| Days Payables Outstanding | 75.49 | 76.7 | 85.44 | 86.91 | 87.67 | 62.9 | |
| Income Quality | (12.5) | 3.68 | 1.35 | 1.3 | (2.34) | (2.22) | |
| Roe | (0.0755) | 0.27 | 0.56 | 0.52 | (0.32) | (0.31) | |
| Ev To Operating Cash Flow | 9.91 | 8.99 | 9.77 | 9.9 | 14.02 | 8.6 | |
| Pe Ratio | (57.34) | 18.64 | 9.1 | 8.23 | (19.73) | (18.75) | |
| Return On Tangible Assets | (0.00734) | 0.0317 | 0.0817 | 0.0768 | (0.0292) | (0.0278) | |
| Ev To Free Cash Flow | 38.13 | 13.43 | 14.76 | 16.71 | 41.9 | 43.99 | |
| Earnings Yield | 0.2 | (0.0174) | 0.0536 | 0.12 | (0.0507) | (0.0481) | |
| Intangibles To Total Assets | 0.024 | 0.0236 | 0.0143 | 0.0151 | 0.0127 | 0.0121 | |
| Net Debt To E B I T D A | 7.18 | 4.14 | 2.06 | 2.25 | 15.72 | 16.5 | |
| Current Ratio | 1.93 | 1.8 | 1.83 | 1.7 | 1.54 | 1.33 | |
| Tangible Book Value Per Share | 3.16 | 3.93 | 5.91 | 6.39 | 4.26 | 7.71 | |
| Receivables Turnover | 8.2 | 9.72 | 8.81 | 10.85 | 9.88 | 6.83 | |
| Graham Number | 5.45 | 12.15 | 23.31 | 24.42 | 13.34 | 22.04 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.